Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.34M | -9.61M | -11.15M | -9.08M | -10.96M |
| Total Depreciation and Amortization | 32.00K | 33.00K | 32.00K | 32.00K | 84.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 511.00K | 307.00K | 227.00K | -166.00K | 1.03M |
| Change in Net Operating Assets | 9.39M | -5.97M | -6.21M | -9.15M | 83.50M |
| Cash from Operations | -407.00K | -15.24M | -17.10M | -18.36M | 73.65M |
| Capital Expenditure | 0.00 | 0.00 | -14.00K | -14.00K | -71.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 24.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.70M | 24.49M | 5.12M | 17.29M | -89.61M |
| Cash from Investing | -6.70M | 24.49M | 5.11M | 17.27M | -89.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.00M | 0.00 | 12.45M | -- | 9.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.00M | 0.00 | 12.45M | -- | 9.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.89M | 9.24M | 459.00K | -1.09M | -6.82M |